GRANISETRON EXTENDED RELEASE INJECTION (GERSC)
UAB1950
Phase 2 small_molecule terminated
Quick answer
GRANISETRON EXTENDED RELEASE INJECTION (GERSC) for Chemotherapy-induced Nausea and Vomiting is a Phase 2 program (small_molecule) at Heron Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Heron Therapeutics
- Indication
- Chemotherapy-induced Nausea and Vomiting
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated